These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16208172

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictive factors of failure in a fixed 15 mCi 131I-iodide therapy for Graves' disease.
    Moura-Neto A, Mosci C, Santos AO, Amorim BJ, de Lima MC, Etchebehere EC, Tambascia MA, Ramos CD, Zantut-Wittmann DE.
    Clin Nucl Med; 2012 Jun; 37(6):550-4. PubMed ID: 22614185
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
    Hou H, Hu S, Fan R, Sun W, Zhang X, Tian M.
    Biomed Res Int; 2015 Jun; 2015():974689. PubMed ID: 25879041
    [Abstract] [Full Text] [Related]

  • 5. [Predictors of the efficacy of radioiodine therapy of Graves' disease in children and adolescents].
    Rumyantsev PO, Saenko VA, Dzeytova DS, Trukhin AA, Sheremeta MS, Slashchuk KY, Degtyarev MV, Serzhenko SS, Yasuchenia VS, Zakharova SM, Sirota YI.
    Probl Endokrinol (Mosk); 2020 Oct 19; 66(4):68-76. PubMed ID: 33351361
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
    Kobe C, Weber I, Eschner W, Sudbrock F, Schmidt M, Dietlein M, Schicha H.
    Nuklearmedizin; 2008 Oct 19; 47(4):153-6. PubMed ID: 18690374
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the factors associated with Tc-99m pertechnetate uptake in thyrotoxicosis and graves' disease.
    Kidokoro-Kunii Y, Emoto N, Cho K, Oikawa S.
    J Nippon Med Sch; 2006 Feb 19; 73(1):10-7. PubMed ID: 16538017
    [Abstract] [Full Text] [Related]

  • 11. Prediction of remission in Graves' disease treated with long-term carbimazole therapy: evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators.
    Prakash R.
    Eur J Nucl Med; 1996 Feb 19; 23(2):118-22. PubMed ID: 8925844
    [Abstract] [Full Text] [Related]

  • 12. Strategies of radioiodine therapy for Graves' disease.
    Lind P.
    Eur J Nucl Med Mol Imaging; 2002 Aug 19; 29 Suppl 2():S453-7. PubMed ID: 12192545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T.
    Clin Endocrinol (Oxf); 1997 Oct 19; 47(4):425-30. PubMed ID: 9404440
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.
    Ikekubo K, Hino M, Ito H, Koh T, Ishihara T, Kurahachi H, Kasagi K, Hidaka A, Mori T.
    Ann Nucl Med; 1990 Jul 19; 4(2):43-8. PubMed ID: 2171608
    [Abstract] [Full Text] [Related]

  • 17. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
    Kasagi K, Hidaka A, Misaki T, Miyamoto S, Takeuchi R, Sakahara H, Sasayama S, Iida Y, Konishi J.
    J Nucl Med; 1994 May 19; 35(5):811-7. PubMed ID: 8176463
    [Abstract] [Full Text] [Related]

  • 18. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU, De Freitas Gomes E, Bae SH, Ulyssea R, Casulari LA.
    Panminerva Med; 2000 Dec 19; 42(4):241-5. PubMed ID: 11294085
    [Abstract] [Full Text] [Related]

  • 19. The effect of short-term treatment with lithium carbonate on the outcome of radioiodine therapy in patients with long-lasting Graves' hyperthyroidism.
    Sekulić V, Rajić M, Vlajković M, Ilić S, Stević M, Kojić M.
    Ann Nucl Med; 2017 Dec 19; 31(10):744-751. PubMed ID: 28895066
    [Abstract] [Full Text] [Related]

  • 20. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G, Reinwein D, Kahaly G, Tegler L, Alexander WD, Fassbinder J, Hirche H.
    Clin Endocrinol (Oxf); 1998 Oct 19; 49(4):451-7. PubMed ID: 9876342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.